Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

171.47
Delayed Data
As of Jul 29
 -1.27 / -0.74%
Today’s Change
122.25
Today|||52-Week Range
174.80
+7.65%
Year-to-Date
3 Stocks Pushing The Drugs Industry Lower
Jul 29 / TheStreet.com
Week in Review, July 25
Jul 24 / FT.com
Janet Yellen Can't Pop The Biotech Bubble (But The SF Gate Can)
Jul 29 / Investing Channel
Shire's (SHPG) Q2 Earnings Lag Estimates, 2015 View Raised - Analyst Blog
Jul 24 / Zacks.com
Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA...
Jul 29 / Zacks.com
The Zacks Analyst Blog Highlights: Amgen, Exelixis, Regeneron, Five Prime Therapeutic...
Jul 23 / Zacks.com
Stock Market News for July 29, 2015 - Market News
Jul 29 / Zacks.com
Amgen's Repatha Gains EU Nod; First PCSK9 Drug Approved - Analyst Blog
Jul 22 / Zacks.com
Jensen's Morning Musings
Jul 29 / TheStreet.com
Amgen Inc. Grabs a Potential Blockbuster Approval
Jul 22 / MotleyFool.com
Will Amgen (AMGN) Keep the Earnings Streak Alive in 2Q? - Analyst Blog
Jul 28 / Zacks.com
Alzheimer's treatment reflects growing hopes for drugmakers
Jul 22 / FT.com
Merck Tops on Q2 Earnings & Revenues, Revises Outlook - Analyst Blog
Jul 28 / Zacks.com
Biotech Stock Roundup: Amgen PCSK9 Inhibitor First to Gain Approval, Exelixis Up on P...
Jul 22 / Zacks.com
Trade-Ideas: Amgen (AMGN) Is Today's Strong On High Relative Volume Stock
Jul 28 / TheStreet.com
2015bs Top 6 Big Pharma Headlines Thus Far
Jul 22 / MotleyFool.com
Benzinga's M&A Chatter for Monday July 27, 2015
Jul 27 / Benzinga
Amgen and Sanofi to battle for cholesterol-busting crown
Jul 22 / FT.com
3 Questions to Ask Ahead of Amgen's Second-Quarter Earnings Release
Jul 27 / MotleyFool.com
Will Abbott Laboratories (ABT) Miss Earnings This Season? - Analyst Blog
Jul 20 / Zacks.com
Is The Biotech Bull Market Still Intact?
Jul 27 / Investing Channel
Amgen Reports Positive Data on Leukemia Drug Blincyto - Analyst Blog
Jul 17 / Zacks.com
Regeneron Pharmaceuticals and Sanofi Grab a Blockbuster FDA Approval
Jul 27 / MotleyFool.com
Will Novartis (NVS) Disappoint Q2 Earnings due to Generics? - Analyst Blog
Jul 17 / Zacks.com
Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog
Jul 27 / Zacks.com
Acquisitive Celgene shuns usual biotech growth model
Jul 16 / FT.com
Stock Market News for July 27, 2015 - Market News
Jul 27 / Zacks.com
Biotech boon as Celgene agrees $7.2bn Receptos deal
Jul 14 / FT.com
Biotech high flyers face gravity test
Jul 27 / FT.com
Drugmakers premiere summer blockbusters
Jul 12 / FT.com
Earnings Growth Hard to Come By - Earnings Preview
Jul 24 / Zacks.com